Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 7/20 | 0.51 |
| ▸ | RXRA | P19793 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.46 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RARA | P10276 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2808366 | 0.95 | RARB (0.56) | RARBTP53TSHRPLA2G4BMEN1 | |
| SCHEMBL27889921 | 0.93 | RARB (0.58) | RARBTP53TSHRPLA2G4BMEN1 | |
| SCHEMBL27889925 | 0.93 | RARB (0.58) | RARBTP53TSHRPLA2G4BMEN1 | |
| SCHEMBL2811083 | 0.93 | RARB (0.58) | RARBTP53TSHRPLA2G4BMEN1 | |
| SCHEMBL27906429 | 0.93 | RARB (0.58) | RARBTP53TSHRPLA2G4BMEN1 | |
| SCHEMBL2809375 | 0.89 | MRGPRX4 (0.48) | RARBRXRATSHRMRGPRX4ALDH1A1 | |
| SCHEMBL21443919 | 0.87 | RARB (0.62) | RARBRXRAMEN1ALDH1A1RARA | |
| SCHEMBL27637429 | 0.87 | MRGPRX4 (0.51) | RXRATP53TSHRMRGPRX4MEN1 | |
| SCHEMBL28407110 | 0.86 | RARB (0.54) | RARBRXRATP53TSHRPLA2G4B | |
| SCHEMBL29827702 | 0.86 | PKM (0.46) | RARBTSHRMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068439-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA North aAmerica S.ar.I (US) | 2010-03-18 | — | — | US | claimed |
| WO-2008095071-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA TECHNOLOGIES S.AR.L. (CH) | 2008-08-07 | — | — | WO | claimed |
| US-4276193-A | MAGNESIUM DIHALIDE CARRIER, CATALYST COMPRISING AN ELECTRON DONOR, TITANIUM TETRACHLORIDE REDUCED WITH AN ORGANOALUMINUM HALIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-06-30 | — | — | US | claimed |
| EP-3604281-A1 | 2(1H)-QUINOLINONE DERIVATIVE | Taisho Pharmaceutical Co., Ltd. (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-3260920-A1 | TONER COMPOSITIONS WITH ANTIPLASTICIZERS | Xerox Corporation (US) | 2017-12-27 | — | — | EP | disclosed |
| US-9684257-B1 | Toner compositions with antiplasticizers | XEROX CORPORATION (US) | 2017-06-20 | — | — | US | disclosed |
| US-8895773-B2 | Manufacture and use of alkyl p-toluates | INVISTA NORTH AMERICA S.A.R.L. (US) | 2014-11-25 | — | — | US | disclosed |
| US-20100068439-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA North aAmerica S.ar.I (US) | 2010-03-18 | — | — | US | disclosed |
| US-20090286912-A1 | MANUFACTURE AND USE OF ALKYL p-TOLUATES | INVISTA NORTH AMERICA S.A R.L. (US) | 2009-11-19 | — | — | US | disclosed |
| WO-2008095071-A1 | POLYESTER COMPOSITION WITH IMPROVED GAS BARRIER PROPERTIES AND ARTICLES THEREOF | INVISTA TECHNOLOGIES S.AR.L. (CH) | 2008-08-07 | — | — | WO | disclosed |
| EP-0008764-B1 | PROCESS FOR THE PREPARATION OF A CATALYST ON A SOLID CARRIER AND ITS USE IN THE POLYMERISATION OF PROPYLENE | BAYER AG (DE) | 1982-09-22 | — | — | EP | disclosed |
| US-4276193-A | MAGNESIUM DIHALIDE CARRIER, CATALYST COMPRISING AN ELECTRON DONOR, TITANIUM TETRACHLORIDE REDUCED WITH AN ORGANOALUMINUM HALIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-06-30 | — | — | US | disclosed |
| EP-0008764-A2 | Process for the preparation of a catalyst on a solid carrier and its use in the polymerisation of propylene | BAYER AG (DE) | 1980-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286912-A1 | MANUFACTURE AND USE OF ALKYL p-TOLUATES | EP300, TERT, NAPEPLD | RARB 2131/4885RXRA 2262/4885TP53 1455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.